Viewing StudyNCT00097214


Ignite Creation Date: 2025-12-18 @ 9:58 AM
Ignite Modification Date: 2025-12-23 @ 9:57 PM
Study NCT ID: NCT00097214
Status: None
Last Update Posted: 2010-04-09 00:00:00
First Post: 2004-11-18 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
Sponsor: None
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-11
Start Date Type: None
Primary Completion Date: 2007-04
Primary Completion Date Type: ACTUAL
Completion Date: 2007-04
Completion Date Type: ACTUAL
First Submit Date: 2004-11-18 00:00:00
First Submit QC Date: None
Study First Post Date: 2004-11-19
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2010-04-08 00:00:00
Last Update Post Date: 2010-04-09 00:00:00
Last Update Post Date Type: ESTIMATED